Arcutis Biotherapeutics, Inc. — Director's Dealing 2021

Feb 17, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Arcutis Biotherapeutics, Inc. (ARQT)
CIK: 0001787306
Period of Report: 2020-12-31

Reporting Person: Lock Kenneth A. (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-31	Common Stock	A	1004	$14.45	Acquired	23100	Direct
2020-11-30	Common Stock	A	233	$23.052	Acquired	23100	Direct

Footnotes

F1: Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan.

F2: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.